Share
337 Posts.
lightbulb Created with Sketch. 62
clock Created with Sketch.
30/11/21
14:58
Share
Originally posted by FrankieAlfie:
↑
This is an important Quarter for the company. A bad quarter and it will hasten a CR and continue negative sentiment. A good one and they can build momentum leading into HP orders, clinical trials and OTC. what are peoples estimates for the sales numbers? My guesstimate is based on : - as at 27th of October TR sales we're in excess of $500000. - if the ratio of TR to DTC sales continued from Q1 then we can extrapolate that the DTC would be around $650000. - so total sales leading into November would be approximately 1.15 million - if sales track at the same rate through to December 24 an additional 2.47 million in sales would be achieved. - total sales for quarter would be 3.62 million. - The best buys B&M roll out happened sometime in November. I'm going to make an assumption that this rollout results in an extra 2 sales per store per week (over 5 week period). That would include another $1 million in sales. For me I'm expecting a a quarter of 4.62 million in sales approx as a worst case scenario. id put the range of 4.62 million up to 5.6 million. Anything above that would be impressive. however I believe this to be very conservative. What I haven't factored in: - increase in sales due to thanksgiving, Black Friday, cyber Monday and Christmas period. I've just assumed a flat continuation of October sales. It is highly likely that these sales result in a increased result. - I haven't calculated Boxing Day sales or included last week of December. - I haven't included additional accessories (39% attachment rate) could be another $500000 - Amazon us sales seem to be showing a small amount of traction. There have been 6 reviews all from mid November. I've not included this but it could be argued that these reviews indicate that there is a larger proportion of sales being made that are not writing reviews. Traditionally only 10% of people leave reviews. So that could equate to 60 sales. An insignificant revenue but it may ramp up. -HP have slashed prices of elites by 1300 dollars. Now are shipping 1st March. Again insignificant but positive direction - Walgreens seems to be showing little action (I would note that when you look at reviews actually read them. There are a couple that are positive but give contradictory scores which skews the overall rating) Further to this I believe that the max are a great product. If others agree with me then "word of mouth" referrals will begin to take effect. The market has become impatient with Nuh. We have had a sell off that has gone to far. To turn around it needs a catalyst. This quarter sales could be it. If so the news pipeline is extremely encouraging: - clinical trials - OTC regulations - HP orders - hearing aid registration - extending into other geographic areas ie Europe... Nuh is a buy for me.
Expand
Majorly optimistic imo but don’t let me burst your bubble.Trouble with opinionated forecasts that lead people to believe in miracles also leads to disappointment.Always the next 1/4.How many 1/4s now,about 20.Was there a positive rerate after any?Maybe,but I don’t recall. PS Would love your predictions to eventuate GLTA.